✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Zenotech Laboratories Ltd.

ZENOTECH

Market Cap
₹360 Cr.
P/E
72.16

Zenotech Laboratories Ltd.

  • Zenotech Laboratorie
  • Vivo Bio Tech
  • Jeevan Scientific
  • TJI Pharma - Small Cap
FAQs on Zenotech Laboratories Ltd. Shareprice

Zenotech Laboratorie has given better returns compared to its competitors.
Zenotech Laboratorie has grown at ~4.88% over the last 7yrs while peers have grown at a median rate of -3.31%

Yes, Zenotech Laboratorie is expensive.
Latest PE of Zenotech Laboratorie is 74.54, while 3 year average PE is 38.78.
Also latest EV/EBITDA of Zenotech Laboratorie is 28.02 while 3yr average is 25.07.

View FAQ's On Business
Growth Table
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Balance Sheet
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Cash Flow
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Quarterly Results
  • Zenotech Laboratories Ltd.
  • Vivo Bio Tech
  • Jeevan Scientific
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Zenotech Laboratories Ltd. Financials

Balance sheet of Zenotech Laboratorie is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Zenotech Laboratorie is increasing.
Latest debt of Zenotech Laboratorie is -₹21.92 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹39.37 Crs.

No, profit is decreasing.
The profit of Zenotech Laboratorie is ₹4.99 Crs for TTM, ₹8.3 Crs for Mar 2024 and ₹11.59 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zenotech Laboratorie latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech